These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 21502077)

  • 21. Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributes.
    Dri DA; Rinaldi F; Carafa M; Marianecci C
    Drug Deliv Transl Res; 2023 Mar; 13(3):757-769. PubMed ID: 36450964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addressing the challenges to increase the efficiency of translating nanomedicine formulations to patients.
    Bhattacharjee S; Brayden DJ
    Expert Opin Drug Discov; 2021 Mar; 16(3):235-254. PubMed ID: 33108229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases.
    Maurya S; Srivastava R; Arfin S; Hawthorne S; Jha NK; Agrawal K; Raj S; Rathi B; Kumar A; Raj R; Agrawal S; Paiva-Santos AC; Malik AA; Dua K; Rana R; Ojha S; Jha SK; Sharma A; Kumar D; El-Zahaby SA; Nagar A
    Nanomedicine (Lond); 2022 Dec; 17(30):2245-2264. PubMed ID: 36975758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanomedicines as cancer therapeutics: current status.
    Akhter S; Ahmad I; Ahmad MZ; Ramazani F; Singh A; Rahman Z; Ahmad FJ; Storm G; Kok RJ
    Curr Cancer Drug Targets; 2013 May; 13(4):362-78. PubMed ID: 23517593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanomaterial Drug Products: Manufacturing and Analytical Perspectives.
    Sayes CM; Aquino GV; Hickey AJ
    AAPS J; 2017 Jan; 19(1):18-25. PubMed ID: 27822601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs.
    Liu Y; Liang Y; Yuhong J; Xin P; Han JL; Du Y; Yu X; Zhu R; Zhang M; Chen W; Ma Y
    Drug Des Devel Ther; 2024; 18():1469-1495. PubMed ID: 38707615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.
    Kompella UB; Amrite AC; Pacha Ravi R; Durazo SA
    Prog Retin Eye Res; 2013 Sep; 36():172-98. PubMed ID: 23603534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of Taiwan's strategies for regulating nanotechnology-based pharmaceuticals harmonized with international considerations.
    Guo JW; Lee YH; Huang HW; Tzou MC; Wang YJ; Tsai JC
    Int J Nanomedicine; 2014; 9():4773-83. PubMed ID: 25342901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges associated and approaches for successful translation of nanomedicines into commercial products.
    Agrahari V; Hiremath P
    Nanomedicine (Lond); 2017 Apr; 12(8):819-823. PubMed ID: 28338401
    [No Abstract]   [Full Text] [Related]  

  • 31. Nanoparticle based medicines: approaches for evading and manipulating the mononuclear phagocyte system and potential for clinical translation.
    Mills JA; Liu F; Jarrett TR; Fletcher NL; Thurecht KJ
    Biomater Sci; 2022 Jun; 10(12):3029-3053. PubMed ID: 35419582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification processes of polymeric nanoparticles: How to improve their clinical translation?
    Tehrani SF; Bharadwaj P; Leblond Chain J; Roullin VG
    J Control Release; 2023 Aug; 360():591-612. PubMed ID: 37422123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Advances in Herbal Nanomedicines for Cancer Treatment.
    Pradhan D; Biswasroy P; Sahu A; Sahu DK; Ghosh G; Rath G
    Curr Mol Pharmacol; 2021; 14(3):292-305. PubMed ID: 32448111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barrier permeation and improved nanomedicine delivery in tumor microenvironments.
    Liu J; Zhang J; Gao Y; Jiang Y; Guan Z; Xie Y; Hu J; Chen J
    Cancer Lett; 2023 May; 562():216166. PubMed ID: 37028698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomedicines and Nanosimilars: Looking for a New and Dynamic Regulatory "Astrolabe" Inspired System.
    Demetzos C; Kavatzikidou P; Pippa N; Stratakis E
    AAPS PharmSciTech; 2020 Jan; 21(2):65. PubMed ID: 31933006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomedicines for the treatment of glaucoma: Current status and future perspectives.
    Zhai Z; Cheng Y; Hong J
    Acta Biomater; 2021 Apr; 125():41-56. PubMed ID: 33601065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomedicines: The magic bullets reaching their target?
    Flühmann B; Ntai I; Borchard G; Simoens S; Mühlebach S
    Eur J Pharm Sci; 2019 Feb; 128():73-80. PubMed ID: 30465818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine: a pharma perspective.
    Brown PD; Patel PR
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(2):125-30. PubMed ID: 25196070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in Nanomedicines for Cancer Treatment.
    do Nascimento T; Todeschini AR; Santos-Oliveira R; de Souza de Bustamante Monteiro MS; de Souza VT; Ricci-Júnior E
    Curr Pharm Des; 2020; 26(29):3579-3600. PubMed ID: 32186271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.